Document Detail

Management of angina pectoris: the role of spinal cord stimulation.
MedLine Citation:
PMID:  19178129     Owner:  NLM     Status:  MEDLINE    
Progress in prevention as well as drug and interventional therapy has improved the prognosis of patients with cardiovascular disorders. Many patients at risk have advanced coronary artery disease (CAD), have had multiple coronary interventions, and present with significant co-morbidity. Despite adequate risk factor modulation and often several revascularization procedures, some of these patients still have refractory angina pectoris. Apart from advanced CAD and insufficient collateralization, the cause is often endothelial dysfunction. For this situation, one treatment option is neuromodulation. Controlled studies suggest that, in patients with chronic refractory angina pectoris, spinal cord stimulation (SCS) provides a relief from symptoms equivalent to that provided by surgical therapy, but with fewer complications and lower rehospitalization rates. SCS may result in significant long-term pain relief with improved quality of life. In patients with refractory angina undergoing SCS, some studies have shown not only a symptomatic improvement, but also a decrease in myocardial ischemia and an increase in coronary blood flow. Discussion is ongoing as to whether this is a direct effect on parasympathetic vascodilation or merely a secondary phenomenon resulting from increased physical activity following an improvement in clinical symptoms. Results from nuclear medical studies have sparked discussion about improved endothelial function and increased collateralization. SCS is a safe treatment option for patients with refractory angina pectoris, and its long-term effects are evident. It is a procedure without significant complications that is easy to tolerate. SCS does not interact with pacemakers, provided that strict bipolar right-ventricular sensing is used. Use in patients with implanted cardioverter defibrillators is under discussion. Individual testing is mandatory in order to assess optimal safety in each patient.
Siegfried Eckert; Dieter Horstkotte
Related Documents :
16352049 - Coffee and coronary heart disease.
19018869 - Patients with acute coronary syndromes have low tissue factor activity and microparticl...
21339189 - Low free testosterone is associated with heart failure mortality in older men referred ...
21356429 - Sudden cardiac death: epidemiology, circadian variation, and triggers.
10329069 - The impact of an end-point committee in a large multicentre, randomized, placebo-contro...
6653129 - Echocardiography during attack of angina pectoris.
12678509 - Improved biochemical preservation of heart slices during cold storage.
631489 - Left-sided heart failure presenting as hepatitis.
1495319 - Transesophageal color flow doppler imaging for aortic insufficiency in patients having ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of cardiovascular drugs : drugs, devices, and other interventions     Volume:  9     ISSN:  1175-3277     ISO Abbreviation:  Am J Cardiovasc Drugs     Publication Date:  2009  
Date Detail:
Created Date:  2009-01-30     Completed Date:  2009-06-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100967755     Medline TA:  Am J Cardiovasc Drugs     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  17-28     Citation Subset:  IM    
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr-University Bochum, Bad Oeynhausen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina Pectoris / physiopathology,  therapy*
Cerebrovascular Circulation / physiology
Collateral Circulation / physiology
Coronary Circulation / physiology
Electric Stimulation Therapy / adverse effects,  methods*
Endothelium, Vascular / metabolism,  physiopathology*
Spinal Cord / physiopathology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl t...
Next Document:  Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic ...